Yinghong Wang - Concepedia

Author

Yinghong Wang

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

M. E. Suarez-Almazor, R Benjamin, Wang Ying-hong, Wang Yinghong, Wang, Yinghong, Y WANG, Y Wang, Y. WANG, Y. Wang, Y.H. Wang

598

Publications

15.5K

Citations

H-Index

144

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Baylor College of Medicine The University of Texas Health Science Center at Houston Imperial College London Cleveland Clinic

About

Yinghong Wang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	7	7	422
2	Health Sciences	7	7	3.8K
3	Education	3	3	111
4	Management	2	2	69
5	Business	1	1	72

Yinghong Wang

104

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Journal of Clinical Oncology ImmunohematologyCancer ImmunosurveillanceAutoimmune DiseaseMedicineImmunology	2018	3.6K
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Yinghong Wang, Diana H. Wiesnoski, Beth A. Helmink, Nature Medicine DysbiosisIntestinal TransplantationMucosal ImmunologyImmunologyUlcerative Colitis	2018	692
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Journal of the National Comprehensive Cancer Network	2019	549
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020 John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Journal of the National Comprehensive Cancer Network	2020	470
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab, Cancer Cell Immune EvasionTumor ImmunologyCancer ImmunosurveillanceImmunologyTumor Immunity	2022	314
Investigation of ginsenosides in different parts and ages of Panax ginseng Wen Shi, Yinghong Wang, J LI, Food Chemistry PeriodontologyPanax GinsengOral BiologyDifferent Parts	2006	249
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review Michael Dougan, Yinghong Wang, Alberto Rubio‐Tapia, Gastroenterology Viral HepatitisImmunologyGastroenterologyHepatitisExpert Review	2020	241
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis Yinghong Wang, Hamzah Abu‐Sbeih, Emily Mao, Inflammatory Bowel Diseases	2018	238
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study Hamzah Abu‐Sbeih, Faisal S. Ali, Dana Alsaadi, Journal for ImmunoTherapy of Cancer	2018	206
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis Hamzah Abu‐Sbeih, Faisal S. Ali, Wenyi Luo, Journal for ImmunoTherapy of Cancer	2018	203

Page 1